Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

4.015 +0.145 (+3.75%)
Streaming Delayed Price Updated: 3:08 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
29 30 Next >
News headline image
Aurora Sky Is No More, Stablecoins Melt Down and SAFE Banking Receives Another Boost ↗
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales, lead financial writer Benjamin A. Smith and millennial entrepreneur Anthony Varrell talk macro market, crypto, the dangers of algorithmic... 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 16, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
News headline image
EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development ↗
Atai Life Sciences (NASDAQ: ATAI), a biotech company leading the development of psychedelic compounds for mental health purposes, issued its financial report for the first quarter of the year, ending... 
Via Benzinga
News headline image
Earnings Scheduled For May 16, 2022 ↗
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Index Imploding ↗
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
News headline image
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 12, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 11, 2022 ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
News headline image
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26 
Via Benzinga
American Billionaire Entrepreneurs Bet Millions on Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From May 9, 2022 ↗
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
News headline image
Psychedelic Stocks Continue To Decline In May ↗
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue. 
Via Talk Markets
News headline image
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16 
Via Benzinga
News headline image
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS: 
Via Benzinga
News headline image
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30 
Via Benzinga
News headline image
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76 
Via Benzinga
News headline image
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward ↗
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions. 
Via Benzinga
News headline image
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80 
Via Benzinga
News headline image
Cathie Wood Finds Elon Musk's Comment On Psychedelics, Ketamine An 'Interesting Thesis' For This Stock ↗
Popular stock picker Cathie Wood said on Sunday she finds Tesla Inc (NASDAQ: TSLA) CEO Elon Musk’s comments on the effectiveness of psychedelics and other plant-based substances as treatments for... 
Via Benzinga
News headline image
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS: 
Via Benzinga
News headline image
ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 28, 2022 ↗
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 27, 2022 ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29 
Via Benzinga
News headline image
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97 
Via Benzinga
News headline image
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
News headline image
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
News headline image
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran ↗
Terran Biosciences is slowly but surely finding its place in the psychedelics industry. 
Via Benzinga
News headline image
Shark Tank's Kevin O'Leary Says Twitter's Biggest Risk Is If Elon Musk 'Goes Away' ↗
Shark Tank investor Kevin O’Leary hopes that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk will be successful in his attempt to take over Twitter (NYSE: 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.